Oligodendroglioma history and symptoms: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(58 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Oligodendroglioma}}
{{Oligodendroglioma}}
 
{{CMG}}{{AE}}{{S.M.}}{{SR}}
{{CMG}}{{AE}}{{SR}}


==Overview==
==Overview==
 
When evaluating a [[patient]] for [[oligodendroglioma]], a [[Detailed balance|detailed]] [[History and Physical examination|history]] of the [[presenting symptom]] (onset, duration, and progression), other [[Association (statistics)|associated]] [[symptoms]], a thorough past [[medical history]] [[review]], and [[review]] of common [[risk factors]] such as [[family history]] of [[brain tumors]]. [[Oligodendroglioma]] is a [[slow]]-[[Growth|growing]], [[Infiltration (medical)|infiltrative]] [[tumor]] that may be [[Clinical|clinically]] silent for many [[Year|years]]. With [[tumor]] progression, [[symptoms]] may vary depending upon the [[Location parameter|location]], [[Size consistency|size]], and [[rate]] of [[tumor]] [[growth]]. [[Oligodendroglioma]] mainly involves the [[frontal lobe]]. [[Symptoms]] [[Association (statistics)|associated]] with [[oligodendroglioma]] include [[seizure]], [[headache]], [[nausea]], [[vomiting]], [[vertigo]], [[visual loss]], [[diplopia]], [[strabismus]], [[Hemiparesis|muscle weakness]], [[numbness]], [[speech difficulties]], [[mood disturbances]], [[personality changes]], [[memory]] [[Problem Solved|problems]], low [[energy]], [[fatigue]], [[Urgency|urge]] to [[sleep]], [[Loss function|loss]] of [[Interest (emotion)|interest]] in [[Activities of daily living|daily activities]], [[abulia]], [[Lack (manque)|lack]] of spontaneity, [[loss of consciousness]] with [[syncope]] (few [[tonic-clonic]] [[Jerking|jerks]]), and classic [[Triad (anatomy)|triad]] of [[headache]], [[nausea]], and [[papilledema]] due to [[raised intracranial pressure]].
==History==
==History==
*While evaluating a [[patient]] for [[oligodendroglioma]], a [[Detailed balance|detailed]] [[History and Physical examination|history]] of the following should be taken:<ref name="pmid21149253">{{cite journal| author=McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H et al.| title=Risk factors for oligodendroglial tumors: a pooled international study. | journal=Neuro Oncol | year= 2011 | volume= 13 | issue= 2 | pages= 242-50 | pmid=21149253 | doi=10.1093/neuonc/noq173 | pmc=PMC3064625 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21149253  }} </ref>
**[[Presenting symptom]]:
***Onset
***Duration
***Progression
**Other [[Association (statistics)|associated]] [[symptoms]]
**A thorough past [[medical history]] [[review]]
**[[Review]] of common [[risk factors]] such as:
***[[Family history]] of [[brain tumors]]


==Symptoms==
==Symptoms==
Common symptoms associated with oligodendroglioma include:<ref name="pmid9684012">{{cite journal| author=Douay X, Daems-Monpeurt C, Labalette P, Blond S, Petit H| title=[Bilateral 3rd cranial nerve palsy disclosing oligodendroglioma]. | journal=Rev Neurol (Paris) | year= 1997 | volume= 153 | issue= 6-7 | pages= 430-2 | pmid=9684012 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9684012  }} </ref><ref name="pmid17553214">{{cite journal| author=Hata N, Shono T, Mizoguchi M, Matsumoto K, Guan Y, Nagata S et al.| title=Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy. | journal=Neurol Res | year= 2007 | volume= 29 | issue= 7 | pages= 723-6 | pmid=17553214 | doi=10.1179/016164107X208068 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17553214  }} </ref>
* [[Oligodendroglioma]] is a slow-growing, [[Infiltration (medical)|infiltrative]] [[tumor]] that may be [[Clinical|clinically]] silent for many [[Year|years]]
*[[Seizure]] (most common presentation)
* [[Asymptomatic]] [[patients]] are [[Diagnose|diagnosed]] based on [[Incidental finding|incidental findings]] at the [[Time series|time]] of [[brain imaging]] [[Performance status|performed]] for another [[Reasoning|reason]] (e.g: [[trauma]], [[migraine headaches]])
*[[Headache]]
* Focal [[Neurological|neurologic]] deficits and generalized [[symptoms]] such as [[headache]] are uncommon at the [[Time series|time]] of [[diagnosis]]
*[[Nausea]]
* With [[tumor]] progression, [[symptoms]] may vary [[Dependent variable|depending]] on following characteristics of [[tumor]]:
*[[Vomiting]]
** [[Location parameter|Location]]
*[[Dysarthria|Changes in speech]]
** [[Size consistency|Size]]
*[[mood disorders|Changes in mood]]
** [[Rate]] of [[tumor]] [[growth]]
*[[personality pathology|Changes in personality]]
* It mainly involves the '''[[frontal lobe]]'''
*[[Visual loss]]
* Common [[symptoms]] [[Association (statistics)|associated]] with [[oligodendroglioma]] include:<ref name="pmid9684012">{{cite journal| author=Douay X, Daems-Monpeurt C, Labalette P, Blond S, Petit H| title=[Bilateral 3rd cranial nerve palsy disclosing oligodendroglioma]. | journal=Rev Neurol (Paris) | year= 1997 | volume= 153 | issue= 6-7 | pages= 430-2 | pmid=9684012 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9684012  }} </ref><ref name="pmid17553214">{{cite journal| author=Hata N, Shono T, Mizoguchi M, Matsumoto K, Guan Y, Nagata S et al.| title=Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy. | journal=Neurol Res | year= 2007 | volume= 29 | issue= 7 | pages= 723-6 | pmid=17553214 | doi=10.1179/016164107X208068 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17553214 }} </ref><ref name="pmid1695334">{{cite journal| author=Ogasawara H, Kiya K, Uozumi T, Sugiyama K, Kawamoto K, Ohta M| title=Multiple oligodendroglioma--case report. | journal=Neurol Med Chir (Tokyo) | year= 1990 | volume= 30 | issue= 2 | pages= 127-31 | pmid=1695334 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1695334  }} </ref><ref name="pmid2308753">{{cite journal| author=Raciti-Daurio C, Caruso J| title=Oligodendroglioma--a case presentation. | journal=Optom Vis Sci | year= 1990 | volume= 67 | issue= 1 | pages= 56-8 | pmid=2308753 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2308753  }} </ref><ref name="pmid24805856">{{cite journal| author=Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B et al.| title=Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. | journal=Am J Surg Pathol | year= 2014 | volume= 38 | issue= 8 | pages= 1058-70 | pmid=24805856 | doi=10.1097/PAS.0000000000000221 | pmc=4322928 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24805856 }} </ref>
*[[Diplopia]]
**[[Seizure]] (usually the first and most common [[Presentation (Obstetrics)|presentation]] in 50-80% of the cases)<ref name="pmid17172614">{{cite journal| author=Cavaliere R, Farace E, Schiff D| title=Clinical implications of status epilepticus in patients with neoplasms. | journal=Arch Neurol | year= 2006 | volume= 63 | issue= 12 | pages= 1746-9 | pmid=17172614 | doi=10.1001/archneur.63.12.1746 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17172614  }} </ref>
*[[Muscle weakness]]
**[[Headache]]
 
**[[Nausea]]
 
**[[Vomiting]]
In anywhere from fifty to eighty percent of cases, the first symptom of an oligodendroglioma is the onset of  activity. They occur mainly in the [[frontal lobe]] thus affecting personality.
**[[Vertigo]]
[[Headaches]] combined with increased [[intracranial pressure]] are also a common symptom of oligodendroglioma. Depending on the location of the tumor, any neurological deficit can be induced, from visual loss, motor weakness and cognitive decline. A [[Computed Tomography]] (CT) or [[Magnetic Resonance Imaging]] (MRI) scan is necessary to characterize the anatomy of this tumor (size, location, heter/homogeneity). However, final diagnosis of this [[tumor]], like most tumors, relies on [[histopathologic]] examination ([[biopsy]] examination).
**'''Focal [[neurological]] deficits''' depending upon [[tumor]] [[Location parameter|location]] ([[symptoms]] usually [[Causes|caused]] by [[local]] [[Tissue (biology)|tissue]] [[Disruption (of schema)|disruption]], [[Mass effect (medicine)|mass effect]] on nearby [[Structure factor|structures]], or [[vasogenic edema]]) include:
***[[hemiparesis|Muscle weakness]]
***[[Numbness]]/[[sensory loss]]
***[[Dysarthria|Changes in speech]]/[[aphasia]]
***[[Visual loss]]/[[visual]] [[Spatial analysis|spatial]] [[dysfunction]]
***[[Diplopia]]
***[[Strabismus]]
**'''[[Cognitive]] [[dysfunction]]''' includes:
***[[Memory]] [[Problem Solved|problems]]
***[[mood disorders|Changes in mood]]
***[[personality pathology|Changes in personality]]
***Low [[energy]]
***[[Fatigue]]
***[[Urgency|Urge]] to [[sleep]]
***[[Loss function|Loss]] of [[Interest (emotion)|interest]] in [[Activities of daily living|daily activities]]
***[[Abulia]] (showing [[abnormal]] inability to act or [[Decision making|make decisions]])
***[[Lack (manque)|Lack]] of spontaneity
**'''[[Increased intracranial pressure]]''' (either due to a [[Large-print|large]] [[mass]] or any [[restriction]] in [[cerebrospinal fluid]] outflow [[Causes|causing]] [[hydrocephalus]]) [[Association (statistics)|associated]] with following [[symptoms]]:
***Classic [[Triad (anatomy)|triad]] that includes:
****[[Headache]]
****[[Nausea]]
****[[Papilledema]]
***[[Loss of consciousness]] with [[syncope]] (maybe [[Association (statistics)|associated]] with a few [[tonic-clonic]] [[Jerking|jerks]])
{| class="wikitable"
|+Oligodendrogliomas symptoms according to tumor site
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Tumor site of involvement}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Clinical features}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Frontal lobe]]'''
|
* [[Weakness]] of one [[Side chain|side]] of the [[Human body|body]]
* [[Personality changes]]
* [[Behavior change|Behavior changes]]
* Difficulty with [[short-term memory]]
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Temporal lobe]]'''
|
* Usually “[[Silent News|silent]]”
* May [[Causes|cause]] few [[symptoms]] such as:
** [[Seizures]]
** [[Language]] [[Problem Solved|problems]]
|}


==References==
==References==
Line 36: Line 85:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Needs content]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 22:26, 18 May 2019

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma history and symptoms

CDC on Oligodendroglioma history and symptoms

Oligodendroglioma history and symptoms in the news

Blogs on Oligodendroglioma history and symptoms

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]

Overview

When evaluating a patient for oligodendroglioma, a detailed history of the presenting symptom (onset, duration, and progression), other associated symptoms, a thorough past medical history review, and review of common risk factors such as family history of brain tumors. Oligodendroglioma is a slow-growing, infiltrative tumor that may be clinically silent for many years. With tumor progression, symptoms may vary depending upon the location, size, and rate of tumor growth. Oligodendroglioma mainly involves the frontal lobe. Symptoms associated with oligodendroglioma include seizure, headache, nausea, vomiting, vertigo, visual loss, diplopia, strabismus, muscle weakness, numbness, speech difficulties, mood disturbances, personality changes, memory problems, low energy, fatigue, urge to sleep, loss of interest in daily activities, abulia, lack of spontaneity, loss of consciousness with syncope (few tonic-clonic jerks), and classic triad of headache, nausea, and papilledema due to raised intracranial pressure.

History

Symptoms

Oligodendrogliomas symptoms according to tumor site
Tumor site of involvement Clinical features
Frontal lobe
Temporal lobe

References

  1. ↑ McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H; et al. (2011). "Risk factors for oligodendroglial tumors: a pooled international study". Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMC 3064625. PMID 21149253.
  2. ↑ Douay X, Daems-Monpeurt C, Labalette P, Blond S, Petit H (1997). "[Bilateral 3rd cranial nerve palsy disclosing oligodendroglioma]". Rev Neurol (Paris). 153 (6–7): 430–2. PMID 9684012.
  3. ↑ Hata N, Shono T, Mizoguchi M, Matsumoto K, Guan Y, Nagata S; et al. (2007). "Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy". Neurol Res. 29 (7): 723–6. doi:10.1179/016164107X208068. PMID 17553214.
  4. ↑ Ogasawara H, Kiya K, Uozumi T, Sugiyama K, Kawamoto K, Ohta M (1990). "Multiple oligodendroglioma--case report". Neurol Med Chir (Tokyo). 30 (2): 127–31. PMID 1695334.
  5. ↑ Raciti-Daurio C, Caruso J (1990). "Oligodendroglioma--a case presentation". Optom Vis Sci. 67 (1): 56–8. PMID 2308753.
  6. ↑ Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B; et al. (2014). "Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients". Am J Surg Pathol. 38 (8): 1058–70. doi:10.1097/PAS.0000000000000221. PMC 4322928. PMID 24805856.
  7. ↑ Cavaliere R, Farace E, Schiff D (2006). "Clinical implications of status epilepticus in patients with neoplasms". Arch Neurol. 63 (12): 1746–9. doi:10.1001/archneur.63.12.1746. PMID 17172614.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Oligodendroglioma_history_and_symptoms&oldid=1568943"